- Home
- VATE vs CLSD Comparison
VATE vs CLSD Comparison
Compare VATE & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- CLSD
- Stock Information
- Founded
- VATE 1994
- CLSD 2011
- Country
- VATE United States
- CLSD United States
- Employees
- VATE N/A
- CLSD N/A
- Industry
- VATE Metal Fabrications
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- CLSD Health Care
- Exchange
- VATE Nasdaq
- CLSD Nasdaq
- Market Cap
- VATE 63.2M
- CLSD 68.4M
- IPO Year
- VATE 1996
- CLSD 2016
- Fundamental
- Price
- VATE $4.69
- CLSD $0.42
- Analyst Decision
- VATE
- CLSD Hold
- Analyst Count
- VATE 0
- CLSD 4
- Target Price
- VATE N/A
- CLSD $4.33
- AVG Volume (30 Days)
- VATE 29.1K
- CLSD 12.9M
- Earning Date
- VATE 08-05-2025
- CLSD 08-08-2025
- Dividend Yield
- VATE N/A
- CLSD N/A
- EPS Growth
- VATE N/A
- CLSD N/A
- EPS
- VATE N/A
- CLSD N/A
- Revenue
- VATE $995,000,000.00
- CLSD $4,166,000.00
- Revenue This Year
- VATE N/A
- CLSD $78.37
- Revenue Next Year
- VATE N/A
- CLSD $17.79
- P/E Ratio
- VATE N/A
- CLSD N/A
- Revenue Growth
- VATE N/A
- CLSD N/A
- 52 Week Low
- VATE $3.25
- CLSD $0.29
- 52 Week High
- VATE $13.79
- CLSD $1.65
- Technical
- Relative Strength Index (RSI)
- VATE 41.27
- CLSD 39.95
- Support Level
- VATE $4.40
- CLSD $0.40
- Resistance Level
- VATE $5.21
- CLSD $0.47
- Average True Range (ATR)
- VATE 0.57
- CLSD 0.06
- MACD
- VATE -0.09
- CLSD 0.01
- Stochastic Oscillator
- VATE 11.89
- CLSD 26.87
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.